Grace Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRCE and other ETFs, options, and stocks.About GRCE
Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil.
CEOPrashant Kohli
CEOPrashant Kohli
Employees—
Employees—
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2002
Founded2002
Employees—
Employees—
GRCE Key Statistics
Market cap48.17M
Market cap48.17M
Price-Earnings ratio-5.32
Price-Earnings ratio-5.32
Dividend yield—
Dividend yield—
Average volume71.61K
Average volume71.61K
High today$3.27
High today$3.27
Low today$3.11
Low today$3.11
Open price$3.27
Open price$3.27
Volume60.77K
Volume60.77K
52 Week high$4.97
52 Week high$4.97
52 Week low$1.75
52 Week low$1.75
Stock Snapshot
Grace Therapeutics(GRCE) stock is priced at $3.11, giving the company a market capitalization of 48.17M. It carries a P/E multiple of -5.32.
As of 2025-11-25, Grace Therapeutics(GRCE) stock has fluctuated between $3.11 and $3.27. The current price stands at $3.11, placing the stock 0.0% above today's low and -4.9% off the high.
The Grace Therapeutics(GRCE)'s current trading volume is 60.77K, compared to an average daily volume of 71.61K.
In the last year, Grace Therapeutics(GRCE) shares hit a 52-week high of $4.97 and a 52-week low of $1.75.
In the last year, Grace Therapeutics(GRCE) shares hit a 52-week high of $4.97 and a 52-week low of $1.75.
People also own
Based on the portfolios of people who own GRCE. This list is generated using Robinhood data, and it’s not a recommendation.